Financhill
Back

Alnylam Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$400.66
Seasonality Move:
2.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Alnylam Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 38.2% based on the past 21 years of stock performance.
  • Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
  • Is Alnylam Pharmaceuticals, Inc. Stock Undervalued?
    The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $400.23. The Score for ALNY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 38.2% based on the past 21 years of stock performance.

Alnylam Pharmaceuticals, Inc. Stock Rating

Sell
48
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. overpriced?

  • Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%

Alnylam Pharmaceuticals, Inc. Stock Price History

Is ALNY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com

52-Week Data

52-Week High:
495.55
52-Week Low:
205.87

Prediction Charts

Market Cap:
52.9B
Price in USD:
400.23
Volume:
12.6M
Beta:
1.19

Technical Analysis

SMA50:
446.50
SMA100:
447.81
SMA200:
365.67
52-Wk Change:
67.55%

Stock Predictions

  • Is Alnylam Pharmaceuticals, Inc. stock public?
    Yes, Alnylam Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Alnylam Pharmaceuticals, Inc. stock quote today?
    The Alnylam Pharmaceuticals, Inc. stock price is 400.23 USD today.
  • How to buy Alnylam Pharmaceuticals, Inc. stock online?
    You can buy Alnylam Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 453.90 464.93 472.48 453.01
Dec-3 466.49 473.29 479.79 460.41
Dec-4 472.67 465.34 477.06 463.03
Dec-5 468.29 458.12 473.50 455.32
Dec-8 447.00 430.02 449.78 423.45
Dec-9 430.45 415.21 433.31 412.31
Dec-10 416.54 404.46 417.00 403.80
Dec-11 403.36 412.63 414.22 402.22
Dec-12 408.86 397.55 410.04 387.03
Dec-15 394.22 391.50 402.33 390.00
Dec-16 390.65 391.17 399.64 388.54
Dec-17 394.18 392.10 400.24 389.00
Dec-18 394.49 396.04 404.19 391.51
Dec-19 399.11 400.23 408.15 395.97

Alnylam Pharmaceuticals, Inc. Earnings

Alnylam Pharmaceuticals, Inc. Earnings Report: Per Share Alnylam Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals, Inc. Forecast Revenue Growth

Alnylam Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.21 per share, and an increase next year of $5.65 per share.

* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.